Fmoc-His(Tos)-OH,
112380-10-6,
Nalpha-Fmoc-Nim-4-toluenesylfonyl-L-histidine,
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(1-tosyl-1H-imidazol-4-yl)propanoic acid,
PubChem18932,
SCHEMBL1738812,
CTK8E9958,
DTXSID40583802,
ZINC2516899,
CF-185,
MFCD00144353,
AKOS015892635,
VA50350,
AX8001894,
RT-014656,
TL8006123,
FT-0642745,
C-23110,
J-002762,
Fmoc-His(Tos)-OH, purum, >=98.0% (calc. based on dry substance, C/N),
L-Histidine,N-[(9H-fluoren-9-ylmethoxy)carbonyl]-1-[(4-methylphenyl)sulfonyl]-,
N-{[(9H-Fluoren-9-yl)methoxy]carbonyl}-1-(4-methylbenzene-1-sulfonyl)-L-histidine,
(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-[1-(4-methylphenyl)sulfonylimidazol-4-yl]propanoic acid,
(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-(1-tosyl-1H-imidazol-4-yl)propanoic acid,
C28H25N3O6S,